Checkpoint Therapeutics, Inc.

Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Checkpoint Therapeutics, Inc. (NASDAQ: CKPT) between March 10, 2021 and December 15, 2023, both dates inclusive (the “Class Period”). A class action lawsuit has already been filed. If you wish to serve as lead plaintiff, you must move the Court no later than June 4, 2024.

If you purchased Checkpoint securities and would like to join the action, please click “Join This Class Action.”

集体诉讼期:March 10, 2021 through December 15, 2023


7 Days
If you purchased Checkpoint secuirites during the Class Period you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.


According to the lawsuit, defendants made false and/or misleading statements and/or failed to disclose that:

  • Checkpoint had overstated its oversight of, and/or its establishment of adequate manufacturing standards and controls over, its third-party contract manufacturers;
  • accordingly, there were one or more issues with Checkpoint’s third-party contract manufacturing organization (“CMO”) for cosibelimab, Checkpoint’s lead antibody product candidate;
  • all the foregoing reduced the likelihood that the Federal Drug Administration would approve the cosibelimab Biologics License Application (“BLA”) in its present form;
  • as a result, the manufacturing, regulatory, and commercial prospects of cosibelimab were overstated; and
  • as a result, Checkpoint’s public statements were materially false and misleading at all relevant times.

No Class Has Been Certified. Until a class is certified, you are not represented by counsel unless you retain one. You may select counsel of your choice. You may also remain an absent class member and do nothing at this point. An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff.

Attorney Advertising. Prior results do not guarantee a similar outcome.

公司名称: Checkpoint Therapeutics, Inc.
股票代号: CKPT
集体诉讼期: March 10, 2021 through December 15, 2023
法院: United States District Court for the Southern District of New York


自 2013 年以来,罗森律师事务所每年都是代表投资者成功提起证券集体诉讼的前四大律所之一。仅 2019 年,本律所就为投资者追回 4.38 亿美元资金。


机构股东服务公司按 2017 年证券集体诉讼索赔数量,罗森律师事务所列为第一名。